CORBUS PHARMACEUTICALS HLDGS's ticker is CRBP and the CUSIP is 21833P103. A total of 107 filers reported holding CORBUS PHARMACEUTICALS HLDGS in Q4 2019. The put-call ratio across all filers is 3.82 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $3,000 | -57.1% | 16,800 | +20.0% | 0.00% | – |
| Q1 2022 | $7,000 | 0.0% | 14,000 | +23.9% | 0.00% | – |
| Q4 2021 | $7,000 | -90.4% | 11,300 | -71.8% | 0.00% | – |
| Q2 2021 | $73,000 | -86.2% | 40,000 | -85.1% | 0.00% | -100.0% |
| Q1 2021 | $529,000 | +812.1% | 268,600 | +482.6% | 0.00% | – |
| Q4 2020 | $58,000 | -86.7% | 46,100 | -11.5% | 0.00% | -100.0% |
| Q2 2020 | $437,000 | +498.6% | 52,100 | +288.8% | 0.00% | – |
| Q4 2019 | $73,000 | -29.1% | 13,400 | -36.8% | 0.00% | – |
| Q3 2019 | $103,000 | – | 21,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 397,168 | $43,888 | 0.01% |
| CJM Wealth Advisers, Ltd. | 30,465 | $3,366 | 0.00% |
| Tekla Capital Management LLC | 154,310 | $17,051 | 0.00% |
| McAdam, LLC | 10,006 | $6 | 0.00% |
| Aries Wealth Management | 15,400 | $1,702 | 0.00% |
| WELLS FARGO & COMPANY/MN | 342,084 | $37,800 | 0.00% |
| JPMORGAN CHASE & CO | 43,415 | $5 | 0.00% |
| NORTHERN TRUST CORP | 207,329 | $22,910 | 0.00% |
| PINNACLE ASSOCIATES LTD | 18,580 | $2,053 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |